TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells
M. d. Looff, W. S. Heng, S. d. Jong, F. A. E. Kruyt
This study investigates how TRAIL induces Src-mediated signaling pathways in apoptosis-resistant NSCLC cells, identifying MEK/ERK, SMAD3, and β-catenin as key contributors to pro-tumorigenic effects.
bioRxiv · Aug 10, 2022 · PreprintCancer Biology